Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eisai’s Breast Cancer Drug Gets Priority Review
Eisai’s Breast Cancer Drug Gets Priority Review
Eisai’s Breast Cancer Drug Gets Priority Review
Submitted by
admin
on June 2, 2010 - 8:24am
Source:
Bloomberg
News Tags:
Eisai
FDA
breast cancer
Eribulin
Headline:
Eisai’s Breast Cancer Drug Gets Priority Review
Do Not Allow Advertisers to Use My Personal information
